the role of lymphodepletion in car t-cell therapy: current knowledge & the need for personalization
Published 7 months ago • 343 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
1:18
the importance of lymphodepletion, an undervalued component of the car-t therapy cycle
-
4:44
optimizing lymphodepletion chemotherapy in car-t therapy recipients
-
1:39
the role of myeloid cells in car-t cell therapy
-
2:16
autosct vs car-t for patients with relapsed lbcl in pr: the role of total metabolic tumor volume
-
1:16
the efficacy of car t-cell therapy in richter’s transformation
-
0:44
the role of allosct for r/r lbcl in the era of car-t therapy
-
0:52
the role of transplantation for patients with mcl in the era of car-t therapy
-
1:50
outcomes of patients with dlbcl following asct and/or car-t
-
1:48
novel immunotherapy approaches in lymphoma: car-t cells, bispecifics & sequencing
-
2:53
autohct in dlbcl in the car-t era
-
0:49
novel targets for car-t therapy in mcl
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
5:11
safety and pk/pd of allo-647 for lymphodepletion for allogeneic car-t
-
2:33
the effect of lymphodepleting agents on rate and severity of toxicities following car-t infusion
-
3:01
phase 1 trial of car t-cell therapy for lymphoma
-
0:54
car t-cell therapy in the field of autoimmune disease
-
1:26
the safety and efficacy of allosct following car-t cell therapy for large b-cell lymphoma
-
1:33
the patient's voice in car t-cell regulatory processes